Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Study of Sarcopenia and Aging Biomarkers by the Metabolomics
Authors not listed
Chang Gung Memorial Hospital · 2017
Abstract
With the rapid growth of the global elderly population, the studies of the biomarkers of the sarcopenia and aging are under investigation in different ways. The investigators use Metabolomics to explore the biomarkers of the sarcopenia and aging of the senior adults.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2017). The Study of Sarcopenia and Aging Biomarkers by the Metabolomics. <em>Chang Gung Memorial Hospital</em>. https://clinicaltrials.gov/study/NCT03121326
Vancouver
Anonymous. The Study of Sarcopenia and Aging Biomarkers by the Metabolomics. Chang Gung Memorial Hospital. 2017.
BibTeX
@misc{anon2017TheStu,
title = {The Study of Sarcopenia and Aging Biomarkers by the Metabolomics},
author = {Anonymous},
journal = {Chang Gung Memorial Hospital},
year = {2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Medicine 2024
Preprint · CC-BY
Validation of biomarkers of aging
Clinics in Geriatric Medicine 2013
Preprint · OA
Normal Cognitive Aging
Innovation in aging 2024
Open access · OA
BIOMARKERS OF AGING AND PRECISION HEALTH CARE FOR OLDER ADULTS
Frontiers in aging
Open access · OA
Inflammatory biomarkers and sarcopenia in older adults
Neuron 2025
Preprint · OA
Astrocytes in aging
Elsevier eBooks 2022
Citation only